Yuwen Zhao,Lixia Qin,Hongxu Pan,Zhenhua Liu,Li Jiang,Yan He,Qian Zeng,Xun Zhou,Xiaoxia Zhou,Yangjie Zhou,Zhenghuan Fang,Zheng Wang,Yaqin Xiang,Honglan Yang,Yige Wang,Kailin Zhang,Rui Zhang,Runcheng He,Xiaoting Zhou,Zhou Zhou,Nannan Yang,Dongxiao Liang,Juan Chen,Xuxiang Zhang,Yao Zhou,Hongli Liu,Penghui Deng,Kun Xu,Ke Xu,Chaojun Zhou,Junfei Zhong,Qian Xu,Qiying Sun,Bin Li,Guihu Zhao,Tao Wang,Ling Chen,Huifang Shang,Weiguo Liu,Piu Chan,Zheng Xue,Qing Wang,Li Guo,Xuejing Wang,Changshui Xu,Zhentao Zhang,Tao Chen,Lifang Lei,Hainan Zhang,Chunyu Wang,Jieqiong Tan,Xinxiang Yan,Lu Shen,Hong Jiang,Zhuohua Zhang,Zhengmao Hu,Kun Xia,Zhenyu Yue,Jinchen Li,Jifeng Guo,Beisha Tang

Abstract:This study aimed to determine the mutational spectrum of familial Parkinson's disease and sporadic early-onset Parkinson's disease (sEOPD) in a mainland Chinese population and the clinical features of mutation carriers. We performed multiplex ligation-dependent probe amplification assays and whole-exome sequencing for 1676 unrelated patients with Parkinson's disease in a mainland Chinese population, including 192 probands from families with autosomal-recessive Parkinson's disease, 242 probands from families with autosomal-dominant Parkinson's disease, and 1242 sEOPD patients (age at onset <= 50). According to standards and guidelines from the American College of Medical Genetics and Genomics, pathogenic/likely pathogenic variants in 23 known Parkinson's disease-associated genes occurred more frequently in the autosomal-recessive Parkinson's disease cohort (65 of 192, 33.85%) than in the autosomal-dominant Parkinson's disease cohort (10 of 242, 4.13%) and the sEOPD cohort (57 of 1242, 4.59%), which leads to an overall molecular diagnostic yield of 7.88% (132 of 1676). We found that PRKN was the most frequently mutated gene (n = 83, 4.95%) and present the first evidence of an SNCA duplication and LRRK2 p.N1437D variant in mainland China. In addition, several novel pathogenic/likely pathogenic variants including LRRK2 (p.V1447M and p.Y1645S), ATP13A2 (p.R735X and p.A819D), FBXO7 (p.G67E), LRP10 (c.322dupC/p.G109Rfs*51) and TMEM230 (c.429delT/p.P144Qfs*2) were identified in our cohort. Furthermore, the age at onset of the 132 probands with genetic diagnoses (median, 31.5 years) was about 14.5 years earlier than that of patients without molecular diagnoses (i.e. non-carriers, median 46.0 years). Specifically, the age at onset of Parkinson's disease patients with pathogenic/likely pathogenic variants in ATP13A2, PLA2G6, PRKN, or PINK1 was significantly lower than that of non-carriers, while the age at onset of carriers with other gene pathogenic/likely pathogenic variants was similar to that of non-carriers. The clinical spectrum of Parkinson's disease-associated gene carriers in this mainland Chinese population was similar to that of other populations. We also detected 61 probands with GBA possibly pathogenic variants (3.64%) and 59 probands with GBA p.L444P (3.52%). These results shed insight into the genetic spectrum and clinical manifestations of Parkinson's disease in mainland China and expand the existing repertoire of pathogenic or likely pathogenic variants involved in known Parkinson's disease-associated genes. Our data highlight the importance of genetic testing in Parkinson's disease patients with age at onset < 40 years, especially in those from families with a recessive inheritance pattern, who may benefit from early diagnosis and treatment.

MDPD: an Integrated Genetic Information Resource for Parkinson's Disease.

[Genetic Study of a Parkinson's Disease Pedigree Caused by Compound Heterozygous Mutations in PARK2 Gene].

Clinical and Functional Evidence for the Pathogenicity of the LRRK2 P.arg1067gln Variant

Identification of Parkinson's Disease-Causing Genes Via Omics Data.

Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project

Uncovering the genetic basis of Parkinson's disease globally: from discoveries to the clinic

Genetic Screening for Mutations in the Nrdp1 Gene in Parkinson Disease Patients in a Chinese Population

The genetic background of Parkinson's disease: current progress and future prospects

Genetic Insights into Sporadic Parkinson's Disease Pathogenesis

Identification of Parkinson’s Disease PACE Subtypes and Repurposing Treatments Through Integrative Analyses of Multimodal Data

Association Studies on mtDNA and Parkinson’s Disease Population Discrimination Using the Statistical Classification

Gene-based Burden Analysis of Damaging Private Variants in PRKN, PARK7 and PINK1 in Parkinson's Disease Cohorts of European Descent

Comprehensive Analysis of Core Genes and Key Pathways in Parkinson's Disease

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

Genetics in Parkinson’s disease, state-of-the-art and future perspectives

Gene–environment Interactions: Key to Unraveling the Mystery of Parkinson's Disease

Genetics of Parkinson's Disease: state-of-the-art and role in clinical settings

The Role Of Genetics In Parkinson'S Disease: A Large Cohort Study In Chinese Mainland Population

Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk

The Exploration of Parkinson’s Disease: a Multi-Modal Data Analysis of Resting Functional Magnetic Resonance Imaging and Gene Data